Europe Orthobiologics Market was worth USD 1.28 billion in 2018 and estimated to be growing at a CAGR of 5.31%, to reach USD 1.65 billion by 2023. Orthobiologics are substances which orthopaedic surgeons use to assist injuries heal more quickly. They are used to make the process of healing of broken bones and injured muscles, tendons, and ligaments better. These products are made from substances which are naturally found in the body. When they are used in higher concentrations, they can help speed up the healing process.
When a muscle, bone or tendon is injured, there is bleeding into the injured area. This bleeding is the base for the healing response. It provides a route for healing factors to reach the injury site. In addition to bleeding, there are three factors which are necessary for healing. All of them are orthobiologic materials. First one is called the matrix, which can be thought of as the house in which the cells live and where they will thrive and eventually make tendon, bone or ligament. Second one is growth factors, which are the many different kinds of proteins which are necessary for cells to work during the healing process. Third is the stem cells, which are special cells in your body which can turn into other types of cells.
The key driving factors of Europe Orthobiologics market are growing orthopaedic disease and musculoskeletal disease burden Europe. Moreover, emerging technological innovations in biomaterials which are used in the production of orthobiologics are expected to accelerate the market demand during the forecast period. These predominantly include advent of recombinant biologic agents, modifications in graft designs, cultured tissue scaffolds and stem cell therapy. These advancements are accompanied with the benefits such as reduced surgical time, enhanced biocompatibility and smaller incisions. Furthermore, these novel solutions are presumed to efficiently reduce the recurrence of post-operative complications, which is expected to boost the orthobiologics market during the forecast period.
The Europe Orthobiologics market is segmented based on product into Viscosupplementation, Products, DBM, Synthetic Orthobiologics, BMP, Allografts, PRP and BMAC. By application, the market is divided into Osteoarthritis and Degenerative Arthritis, Spinal Fusion, Fracture Recovery, Soft Tissue Injuries and Maxillofacial & Dental Applications. By end users, the market is divided into Hospitals, Orthopaedic Clinics, Ambulatory Care Centres, Research and Academic Institutes and Dental Clinics & Facilities.
The Europe Orthobiologics market is divided based on geography into United Kingdom, France, Itay, Germany and Spain. Europe has the second largest market for orthobiologics in the world by share. Factors such as growing incidence of musculoskeletal and orthopaedic diseases and rising government support are expected to drive the market growth in the region.
Some of the major players in the market are Medtronic, DePuy Synthes, Zimmer Biomet, Bioventus, Stryker, Harvest Technologies, Globus, Orthofix International, RTI Surgical, K2M Group, Kuros Biosciences among others.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Viscosupplementation
5.1.2 Products
5.1.3 Demineralized Bone Matrices
5.1.4 Synthetic Orthobiologics
5.1.5 Bone Morphogenic Protein
5.1.6 Allografts
5.1.7 Plasma-Rich Protein
5.1.8 Bone Marrow Aspirate Concentrate
5.1.9 Y-o-Y Growth Analysis, By Product
5.1.10 Market Attractiveness Analysis, By Product
5.1.11 Market Share Analysis, By Product
5.2 Application
5.2.1 Osteoarthritis and Degenerative Arthritis
5.2.2 Spinal Fusion
5.2.3 Fracture Recovery
5.2.4 Soft Tissue Injuries
5.2.5 Maxillofacial & Dental Applications
5.2.6 Y-o-Y Growth Analysis, By Application
5.2.7 Market Attractiveness Analysis, By Application
5.2.8 Market Share Analysis, By Application
5.3 End Users
5.3.1 Hospitals
5.3.2 Orthopaedic Clinics
5.3.3 Ambulatory Care Centres
5.3.4 Research and Academic Institutes
5.3.5 Dental Clinics & Facilities
5.3.6 Y-o-Y Growth Analysis, By End Users
5.3.7 Market Attractiveness Analysis, By End Users
5.3.8 Market Share Analysis, By End Users
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Product
6.1.3.2 By Application
6.1.3.3 By End Users
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Product
6.1.4.2 By Application
6.1.4.3 By End Users
6.1.5 Market Share Analysis
6.1.5.1 By Product
6.1.5.2 By Application
6.1.5.3 By End Users
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Medtronic
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 DePuy Synthes
8.3 Zimmer Biomet
8.4 Bioventus
8.5 Stryker
8.6 Harvest Technologies
8.7 Globus
8.8 Orthofix International
8.9 RTI Surgical
8.10 K2M Group
8.11 Kuros Biosciences
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
